A recent study indicates that individuals who come off blockbuster slimming jabs like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional lifestyle regimens.
Research printed in a leading health publication demonstrates that while overweight individuals can lose substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be cognizant of the potential of quick rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.
This pace of recovery suggests a return to starting weight in about a year and a half.
Analyzing Treatments
The study, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with older methods.
Researchers emphasize that individuals who shed pounds through diet and exercise generally experience a more gradual weight regain—perhaps 100 grams monthly—once they finish.
The Reason for the Fast Rebound
Doctors suggest the mechanism of the injections explains the amplified regain.
These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts say that, given the high risk of relapse, the therapy should be considered ongoing.
This view is supported by pharmaceutical companies, who state that the results "emphasize the chronic nature of excess weight," akin to managing conditions like high blood pressure.
User Accounts
People who have come off the jabs explain a intense return of appetite.
"I experienced something activating and you become ravenous," said one woman.
This difficulty is worsened if patients have not adopted lasting lifestyle or habit changes during treatment.
Growing Use
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is greater among women compared to males.
- The middle-aged age group shows the highest usage rates.
- Many access the drugs through private healthcare rather than public health services.
Finally, clinicians stress that while the jabs are effective tools for weight loss, they are not a magic cure and long-term success likely depends on integrated behavioural management.
